Medscape

Embolic Agent Beneficial in Nonsurgical Subdural Hematoma

Subdural hematoma with mild symptoms progressed significantly less often when treated with middle meningeal artery (MMA) embolization compared with observation alone, new results from the second phase ...
Seeking Alpha

Johnson & Johnson Receives FDA Approval for TRUFILL n‑BCA Liquid Embolic System for the Treatment of Symptomatic Chronic Subdural Hematoma

- TRUFILL n-BCA is now indicated for embolization of the middle meningeal artery (MMA) for the treatment of symptomatic subacute and Chronic Subdural Hematoma (cSDH) as an adjunct to surgery. - ...
Business Wire

Viz.ai Receives First and Only FDA 510(k) Clearance for Subdural Measurements

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) ...
Nasdaq

FDA Approves Expanded Use Of Johnson & Johnson's TRUFILL N-BCA For Subdural Hematoma

(RTTNews) - Johnson & Johnson MedTech, the medical technology arm of Johnson & Johnson (J&J) on Thursday said the U.S. Food and Drug Administration (FDA) has approved an expanded indication for its ...
Nature

Order and Timing of Middle Meningeal Artery Embolization as a Perioperative Adjunct to Surgical Evacuation for Chronic Subdural Hematomas: A Multicenter Study.

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
FierceBiotech

Following Medtronic, J&J nets liquid embolic nod in subdural hematoma

Earlier this month, Medtronic received a new approval from the FDA for its decades-old liquid embolic system, extending its use to treat certain kinds of internal brain bleeds. Now, Johnson & Johnson ...